News Conference News ACC 2012 Coronary CTA Effective, Efficient in Ruling Out Patients With Suspected ACS Jason Kahn March 26, 2012
News Daily News Hemodynamic Index Helps Define Impact of Aortic Regurgitation After TAVR March 21, 2012
News Daily News Carbon Dioxide Angiography Safe, Preserves Renal Function in EVAR Jason Kahn March 08, 2012
News Daily News Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’ Yael L. Maxwell March 07, 2012
News Daily News IMPACTO Contradictorio IRM Cardíacas: Más Sensibles que la SPECP pero Menos Específicas March 07, 2012
News Daily News La RMC es Mejor que la SPECT para el Diagnóstico de la EAC en Valoraciones llevadas a cabo en el ‘Mundo Real’ March 06, 2012
News Daily News Medical Societies Issue Position Paper in Anticipation of Transcatheter Valve Availability L.A. McKeown March 06, 2012
Presentation La TC en 3-D del Anillo Aórtico Predice la Regurgitación Paravalvular Severa tras una TAVR Presenter: A. Wilson February 22, 2012
Presentation 3-D Aortic Annular CT Predicts Moderate, Severe Paravalvular Regurgitation After TAVR Presenter: A. Wilson February 22, 2012
News Daily News Interventional Issues Featured in AHA/ASA ‘Top 10’ Research Reports of 2011 February 07, 2012
News Industry News Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization December 19, 2011
News Daily News Balloon Occlusion Bests Filter in Cerebral Protection After Carotid Stenting Yael L. Maxwell November 28, 2011
News Daily News Stress Testing More Likely Among Physicians Who Bill for Such Services Leah Lawrence November 27, 2011
News Industry News REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES November 13, 2011
News Industry News Use of proximal balloon occlusion results in fewer cerebral ischemic lesions than filters after carotid artery stenting November 10, 2011
News Industry News Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial November 08, 2011